Assisted reproductive technologies (ART) such as in-vitro fertilization (IVF) face an uncertain future as anti-abortion policymakers and advocates work to restrict access to reproductive care post-Dobbs.
In light of this changing landscape, we asked experts in law and medicine to reflect on pressing issues at the intersection of ART and current legal debates, such as potential implications of fetal personhood legislation, the future of IVF post-Dobbs, divergent state approaches to sperm and egg donor anonymity, workplace policies supporting access to fertility preservation. Their responses comprise this symposium, which is guest edited by Seema Mohapatra.
Editor-in-Chief: Chloe Reichel